About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 439 record(s)
Req # A-2020-001007
Adverse Reaction Report (AER) for GLYCERYL TRINITRATE. Report number: E2B_02745406.Organization: Health Canada
December 2020
Req # A-2020-001122
Adverse Reaction Reports (AERs) for FLUDARABINE PHOSPHATE. Report numbers: 000908526, 000909469, 000909541, 000909779, 000910534, 000910542.Organization: Health Canada
December 2020
Req # A-2020-001124
Adverse Reaction Reports (AERs) for ZOPICLONE. Report numbers: 000909379, 000912495.Organization: Health Canada
December 2020
Req # A-2020-001143
Adverse Reaction Report (AER). Report number: 000916199.Organization: Health Canada
December 2020
Req # A-2020-001254
Adverse Reaction Reports (AERs). Report numbers: 000685036, 000697145, 000698339, 000701161, 000703768, 000710404, 000713698, 000716262, 000724482, E2B_02714873, 000736289.Organization: Health Canada
December 2020
Req # A-2019-001975
All talking points and communication notes that a specific individual referenced in making a claim to a February 21, 2020 CBC story. Records containing the 'evidence' referenced in the quote, particularly records containing evidence that shows "lower prices do not limit access to new medicines".Organization: Health Canada
December 2020
Req # A-2020-26
From January 1, 2011 to September 3, 2020: 1. The Translation Bureau's “translation memory” tool, and in particular the “Megacorpus”; 2. The Translation Bureau's neural translation tool; 3. The work carried out, for the evaluation of the tools, by the NRC 4. An economic analysis, if applicable, of the impact on salaried translators (CNRC-BT) as well as contract workers; 5. Document search - reports, briefings and memos - in final version.Organization: National Research Council Canada
December 2020
Req # A-2020-40
Copies of all analysis related to proposed changes to the National Building Code 2020; include any analysis or estimates on what the proposed changes would do to the cost of a new home in Canada.Organization: National Research Council Canada
December 2020
Req # A-2020-42
Briefing note, "Approval of the Evaluation of the Human Health Therapeutics Research Centre", Ref # BN20-09-52Organization: National Research Council Canada
December 2020